CONSTELLATION PHARMCETICLS I - COM (CNST)

CUSIP: 210373106

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM
Total 13F shares
51,737,664
Share change
+1,202,807
Total reported value
$1,211,904,602
Put/Call ratio
150%
Price per share
$23.39
Number of holders
128
Value change
+$24,169,267
Number of buys
57
Number of sells
58

Quarterly Holders Quick Answers

What is CUSIP 210373106?
CUSIP 210373106 identifies CNST - CONSTELLATION PHARMCETICLS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CONSTELLATION PHARMCETICLS I - COM (CNST) as of Q1 2021

As of 31 Mar 2021, CONSTELLATION PHARMCETICLS I - COM (CNST) was held by 128 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,737,664 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, VR Adviser, LLC, Avoro Capital Advisors LLC, BlackRock Inc., The Column Group LLC, RA CAPITAL MANAGEMENT, L.P., STATE STREET CORP, LORD, ABBETT & CO. LLC, Ponoi Management, LLC, and Casdin Capital, LLC. This page lists 128 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.